arcadia pharmaceuticals limited Company Information
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
unit 3 bell court, swansea west business park ffore, swansea, SA5 4HP
Website
www.arcadiapharma.co.ukarcadia pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of ARCADIA PHARMACEUTICALS LIMITED at £0 based on a Turnover of £0 and 0.6x industry multiple (adjusted for size and gross margin).
arcadia pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of ARCADIA PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £0 and a 4.34x industry multiple (adjusted for size and gross margin).
arcadia pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of ARCADIA PHARMACEUTICALS LIMITED at £227 based on Net Assets of £99 and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Arcadia Pharmaceuticals Limited Overview
Arcadia Pharmaceuticals Limited is a live company located in swansea, SA5 4HP with a Companies House number of 08708305. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in September 2013, it's largest shareholder is arcadia pharma ltd with a 100% stake. Arcadia Pharmaceuticals Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Arcadia Pharmaceuticals Limited Health Check
There is insufficient data available to calculate a health check for Arcadia Pharmaceuticals Limited. Company Health Check FAQs


0 Strong

0 Regular

0 Weak

Size
There is insufficient data available for this Key Performance Indicator!
- - Arcadia Pharmaceuticals Limited
- - Industry AVG

Growth
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Production
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Profitability
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Employees
There is insufficient data available for this Key Performance Indicator!
- - Arcadia Pharmaceuticals Limited
- - Industry AVG

Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Efficiency
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Arcadia Pharmaceuticals Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Arcadia Pharmaceuticals Limited
- - Industry AVG

Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Arcadia Pharmaceuticals Limited
- - Industry AVG
ARCADIA PHARMACEUTICALS LIMITED financials

Arcadia Pharmaceuticals Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £99. According to their latest financial statements, we estimate that Arcadia Pharmaceuticals Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||
Other Income Or Grants | ||||||||||
Cost Of Sales | ||||||||||
Gross Profit | ||||||||||
Admin Expenses | ||||||||||
Operating Profit | ||||||||||
Interest Payable | ||||||||||
Interest Receivable | ||||||||||
Pre-Tax Profit | ||||||||||
Tax | ||||||||||
Profit After Tax | ||||||||||
Dividends Paid | ||||||||||
Retained Profit | ||||||||||
Employee Costs | ||||||||||
Number Of Employees | ||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | ||||||||||
Intangible Assets | ||||||||||
Investments & Other | 99 | 99 | 99 | 99 | 99 | |||||
Debtors (Due After 1 year) | ||||||||||
Total Fixed Assets | 99 | 99 | 99 | 99 | 99 | |||||
Stock & work in progress | ||||||||||
Trade Debtors | ||||||||||
Group Debtors | ||||||||||
Misc Debtors | ||||||||||
Cash | ||||||||||
misc current assets | ||||||||||
total current assets | ||||||||||
total assets | 99 | 99 | 99 | 99 | 99 | |||||
Bank overdraft | ||||||||||
Bank loan | ||||||||||
Trade Creditors | ||||||||||
Group/Directors Accounts | ||||||||||
other short term finances | ||||||||||
hp & lease commitments | ||||||||||
other current liabilities | ||||||||||
total current liabilities | ||||||||||
loans | ||||||||||
hp & lease commitments | ||||||||||
Accruals and Deferred Income | ||||||||||
other liabilities | ||||||||||
provisions | ||||||||||
total long term liabilities | ||||||||||
total liabilities | ||||||||||
net assets | 99 | 99 | 99 | 99 | 99 | |||||
total shareholders funds | 99 | 99 | 99 | 99 | 99 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | ||||||||||
Depreciation | ||||||||||
Amortisation | ||||||||||
Tax | ||||||||||
Stock | ||||||||||
Debtors | ||||||||||
Creditors | ||||||||||
Accruals and Deferred Income | ||||||||||
Deferred Taxes & Provisions | ||||||||||
Cash flow from operations | ||||||||||
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | 99 | |||||||||
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | ||||||||||
Group/Directors Accounts | ||||||||||
Other Short Term Loans | ||||||||||
Long term loans | ||||||||||
Hire Purchase and Lease Commitments | ||||||||||
other long term liabilities | ||||||||||
share issue | ||||||||||
interest | ||||||||||
cash flow from financing | ||||||||||
cash and cash equivalents | ||||||||||
cash | ||||||||||
overdraft | ||||||||||
change in cash |
arcadia pharmaceuticals limited Credit Report and Business Information
Arcadia Pharmaceuticals Limited Competitor Analysis

Perform a competitor analysis for arcadia pharmaceuticals limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in SA5 area or any other competitors across 12 key performance metrics.
arcadia pharmaceuticals limited Ownership
ARCADIA PHARMACEUTICALS LIMITED group structure
Arcadia Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
1 parent
ARCADIA PHARMACEUTICALS LIMITED
08708305
arcadia pharmaceuticals limited directors
Arcadia Pharmaceuticals Limited currently has 1 director, Mr Michael Overy serving since Sep 2013.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Overy | 78 years | Sep 2013 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
99
0%
total assets
99
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
arcadia pharmaceuticals limited company details
company number
08708305
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
September 2013
age
12
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
unit 3 bell court, swansea west business park ffore, swansea, SA5 4HP
Bank
-
Legal Advisor
-
arcadia pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to arcadia pharmaceuticals limited.
arcadia pharmaceuticals limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ARCADIA PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
arcadia pharmaceuticals limited Companies House Filings - See Documents
date | description | view/download |
---|